期刊文献+

肝癌组织特异性P_(afp)IRES2-EGFP表达载体的构建及表达

Construction of Murine Hepatoma Specific P_(afp)IRES2-EGFP Vector and Its Expression in H22 Cells
下载PDF
导出
摘要 目的构建AFP最小启动子调控的小鼠肝癌组织特异性表达载体,观察其在小鼠H22肝癌细胞中的特异性表达。方法从H22细胞总DNA和荧光载体pIRES2-EGFP中分别PCR扩增AFP最小启动子区序列和CMV增强子(ECMV),利用重叠延伸PCR方法(SOE)获得AFP启动子驱动的嵌合调控序列,将其克隆入pIRES2-EGFP载体,进行菌落PCR、限制性酶谱分析、DNA序列测定。通过jetPEI方法转染H22肝癌细胞和YAC1淋巴瘤细胞,荧光显微镜下观察其表达的组织特异性。结果从小鼠H22细胞DNA和pIRES2-EGFP中分别扩增得到229bp和324bp的片段,纯化后的PCR产物通过SOE扩增得到一537bp的条带,均与预期序列长度一致。SOE产物与pIRES2-EGFP连接,菌落PCR鉴定获得数个阳性克隆,质粒经Nde I+NheⅠ限制性酶谱分析酶解出537bp条带,DNA序列分析证实重组载体中的嵌合DNA与GeneBank中小鼠AFP启动子和ECMV序列完全一致。结论本研究成功构建了AFP启动子调控的小鼠肝癌组织特异性表达载体PafpIRES2-EGFP,该载体能够在小鼠肝癌细胞中特异性表达外源基因。 Objective To establish a novel minimal AFP promoter operated hepatoma specific expression vector and analysis its specific expression in H22 cells. Methods Genomic DNA from H22 hepatoma cells was used to amplify the minimal AFP promoter through PCR, CMV enhancer was prepared by PCR using pIRES2-EGFP as template. The two DNA fragments were spliced through overlapping PCRto form a chimeric promoting sequence. Purified product digested by Nde I and Nhe I was cloned into pIRES2-EGFP to construct the minimal AFP promoter operated murine hepatoma specific PafpIRES2-EGFP expression vector which was verified by PCR screening, restriction enzyme assay( Nde I and Nhe I ) and DNA sequencing. Then purified Pafp IRES2-EGFP plasmid was transfected into H22 hepatoma cells and YAC- 1 lymphoma cells through a jetPEl mediated method. Tissue specific expression the recombinant vector was analyzed by fluorescent microscopy. Results A 229bp and a 324bp DNA segments were amplified respectively from genomic DNA of H22 cells and pIRES2-EGFP. Purified PCR products when spliced by SOE PCR which produced a chimeric DNA sequence of 537bp in length as expected. SOE product and pIRES2-EGFP digested with Nde I and Nhe I respectively were ligated together by Tn liagase,in the following colony PCR it was showed that we got several positive clones,when further assessed by restriction enzyme assay, they gave rise to a 537bp DNA fragment which was finally proved to be identical to the minimal AFP promoter and ECMV. The recombinant vector were then transfected into H22 hepatoma cells and YAC-1 cells by jetPEI,bright green fluorescence could be observed only on the cell surface of H22 cell rather than YAC-I cells at 48h after transfection. Conclusion The Authors successfully constructed a murine hepatoma specific expression vector Pafp IRES2-EGFP operated by the minimal AFP promoter,the recombinant vector could express exogenous gene effectively in murine hepatoma cells.
出处 《潍坊医学院学报》 2008年第3期199-201,I0001,共4页 Acta Academiae Medicinae Weifang
基金 山东省优秀中青年科学家科研奖励基金(2004BSB14074) 山东省卫生高层次人才1020工程专项基金 教育部科学技术研究项目重点项目(205090) 山东省自然科学基金(Y2007C044)
关键词 肝癌 组织特异性表达 AFP启动子 Hepatoma Tissue specific expression AFP promoter
  • 相关文献

参考文献10

  • 1Skin E, Dincer S. Gene delivery:intelligent but just at the be-ginning [J]. Biomater Sci Polym Ed ,2004 ,15 ( 9 ) :1181 - 1202.
  • 2Shibata T, Giaccia A J, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy [ J ]. Gene Ther,2000,7 (6) :493-498.
  • 3Willhauck MJ, Sharif Samani BR, Klutz K, et al. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma[J]. Gene Ther,2008,15(3 ) :214 -223.
  • 4Knneko S, Hallenbeck P, Kotani T, et al. Adenovirus-mediated gene therapy of hepaiocellular carcihoma using cancer-specific gene expression [ J ]. Cancer Res, 1995,55 (22) :5283 - 5287.
  • 5Schmitz V, Qian C, Ruiz J, et al. Gene therapy for liver diseases:recent strategies for treatment of viral hepatitis and liver malignancies [J]. Gut,2002,50( 1 ) : 130 - 135.
  • 6Iimuro Y,Fujimoto J. Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma [ J ]. J Hepatobiliary Pancreat Surg ,2003 ,10 ( 1 ) :45 -47.
  • 7Takikawa H, Mafune K, Hamada H, et al. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma[ J]. Int J Oncol,2003,22 (5) : 1051 - 1056.
  • 8Meng WS, Butterfield LH, Ribas A, et al. Alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination [ J ]. Cancer Res ,2001,61:8782 - 8786.
  • 9Ido A,Uto H,Moriuchi A,et al. Gene therapy targeting for hepatocellular carcinoma:selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-feto- protein promoter[ J]. Cancer Res,2001,61:3016 - 3021.
  • 10Zhang DE, Rabek JP. Functional analysis of the mouse alpha-fetoprotein enhancers and their subfragments in primary mouse hepatocyte cultures [ J ]. J Biol Chem, 1992,267 ( 15 ) : 10 676 - 10 682.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部